INVESTIGATION OF IMMUNOGENICITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUSГ. М. Тарасова, Т. В. Попкова, Б. С. Белов et al.|Rheumatology Science and Practice|2018Cited by 7
FRI0212 USE OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: THE RELATIONSHIP OF IMMUNOGENICITY WITH THERAPYGalina Tarasova, Т. В. Попкова, S. К. Solovyev et al.|Annals of the Rheumatic Diseases|2019Cited by 7